Patents by Inventor Connor Weidle

Connor Weidle has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MASP-2 INHIBITORS AND METHODS OF USE
    Publication number: 20250122225
    Abstract: The disclosure provides synthetic compositions useful as inhibitors of mannan-binding lectin-associated serine protease-2 (MASP-2), including inhibitors that selectively inhibit MASP-2 over thrombin, as well as methods for the manufacture and use thereof.
    Type: Application
    Filed: October 4, 2024
    Publication date: April 17, 2025
    Applicant: Omeros Corporation
    Inventors: Neil S. Cutshall, Melinda Renee Davis, Jennifer Lynn Gage, Sara Rebecca Goldstein, Do Yeon Kwon, Robert Huerta Lemus, Thomas L. Little, Markus Metz, Jeremiah H. Nguyen, Peter Kurt Nollert von Specht, Jennifer Tsoung, Sudheer Babu Vaddela, Connor Weidle
  • MASP-2 INHIBITORS AND METHODS OF USE
    Publication number: 20240228499
    Abstract: The disclosure provides synthetic compositions useful as inhibitors of mannan-binding lectin-associated serine protease-2 (MASP-2), including compositions that selectively inhibit MASP-2 over thrombin, as well as methods for the manufacture and use thereof.
    Type: Application
    Filed: November 29, 2023
    Publication date: July 11, 2024
    Applicant: Omeros Corporation
    Inventors: Neil S. Cutshall, Jennifer Lynn Gage, Do Yeon Kwon, Thomas L. Little, Markus Metz, Peter Kurt Nollert von Specht, Jennifer Tsoung, Sudheer Babu Vaddela, Connor Weidle
  • CIRCUMSPOROZOITE PROTEINS WITH INCREASED EXPRESSION IN MAMMALIAN CELLS
    Publication number: 20240075121
    Abstract: Mutated and/or truncated malarial circumsporozoite proteins (CSP) and associated nucleic acids that are more stable and highly expressed in mammalian cells are described. The mutated and/or truncated CSP and associated nucleic acids can be expressed to produce malaria vaccine antigens.
    Type: Application
    Filed: October 5, 2023
    Publication date: March 7, 2024
    Applicant: Fred Hutchinson Cancer Center
    Inventors: Marie Pancera, Connor Weidle
  • Circumsporozoite proteins with increased expression in mammalian cells
    Patent number: 11896655
    Abstract: Mutated and/or truncated malarial circumsporozoite proteins (CSP) and associated nucleic acids that are more stable and highly expressed in mammalian cells are described. The mutated and/or truncated CSP and associated nucleic acids can be expressed to produce malaria vaccine antigens.
    Type: Grant
    Filed: March 18, 2020
    Date of Patent: February 13, 2024
    Assignee: Fred Hutchinson Cancer Center
    Inventors: Marie Pancera, Connor Weidle
  • CIRCUMSPOROZOITE PROTEINS WITH INCREASED EXPRESSION IN MAMMALIAN CELLS
    Publication number: 20220280626
    Abstract: Mutated and/or truncated malarial circumsporozoite proteins (CSP) and associated nucleic acids that are more stable and highly expressed in mammalian cells are described. The mutated and/or truncated CSP and associated nucleic acids can be expressed to produce malaria vaccine antigens.
    Type: Application
    Filed: March 18, 2020
    Publication date: September 8, 2022
    Applicant: Fred Hutchinson Cancer Research Center
    Inventors: Marie Pancera, Connor Weidle